Biotech companies 🧬 have received significant VC funding in the past three years. As a result, industry innovators have applied next-gen strategies to improve efficiency and ultimately reach more goals. Read our insights to learn more ➡️ https://t.co/MMFAcPTZ5L pic.twitter.com/08R11QyvJi
— McKinsey & Company (@McKinsey) June 27, 2022
Leave a Reply